Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-15-002854
Filing Date
2015-12-23
Accepted
2015-12-23 16:43:34
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13da210109002_12232015.htm SC 13D/A 67068
2 ex1to13da210109002_12232015.htm EX-1 181933
  Complete submission text file 0000921895-15-002854.txt   250526
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Subject) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82467 | Film No.: 151306248
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1275 YORK AVE. NEW YORK NY 10065
Business Address 1275 YORK AVE. NEW YORK NY 10065 212-639-2000
Memorial Sloan-Kettering Cancer Center (Filed by) CIK: 0001566787 (see all company filings)

EIN.: 000000000 | State of Incorp.: NY
Type: SC 13D/A